Recent settlements between the U.S. Federal Trade Commission (FTC) and six CBD operators underscore the latest attempt to curtail long-running mislabeling concerns.
It’s important to really monitor your symptoms rather than trying to lock in a particular milligram that you think is beneficial to you.
I think sometimes we put a little too much work into really thinking about what the starting...